COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC

被引：0
|
作者：
Pettigrew, M. [1 ]
Thirion, D. J. [2 ]
Libman, M. [3 ]
Zanotti, G. [4 ]
机构：
[1] Symbiose, Montreal, PQ, Canada
[2] Univ Montreal, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[4] Pfizer Canada Inc, Kirkland, PQ, Canada
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.648
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A116 / A116
页数：1
相关论文
共 50 条
  • [31] Cost of nosocomial pneumonia: the example of vancomycin versus linezolid-shorter stay or fewer complications?
    Rello, Jordi
    Bin, Cao
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 51 : 1 - 3
  • [32] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN COLOMBIA
    Diaz-Sotelo, O. D.
    Barbosa Castro, T.
    Ortiz, Vecino A.
    Quevedo, Mould J. F.
    Vargas Zea, N.
    Prieto Martinez, V
    VALUE IN HEALTH, 2013, 16 (03) : A92 - A92
  • [33] Linezolid for the treatment of skin and soft-tissue MRSA infections - A cost-effective alternative to vancomycin: Evidence from a multinational clinical trial
    Sorensen, SV
    Hollenbeak, CS
    Baker, TM
    Resch, A
    Duttagupta, S
    VALUE IN HEALTH, 2004, 7 (06) : 758 - 759
  • [34] Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
    Mathias W Pletz
    Olaf Burkhardt
    Tobias Welte
    European Journal of Medical Research, 15
  • [35] The Efficacy and Safety of Arbekacin and Vancomycin for the Treatment in Skin and Soft Tissue MRSA Infection: Preliminary Study
    Hwang, Ji-Hee
    Lee, Ju-Hyung
    Moon, Mi-Kyoung
    Kim, Ju-Sin
    Won, Kyoung-Suk
    Lee, Chang-Seop
    INFECTION AND CHEMOTHERAPY, 2013, 45 (01): : 62 - 68
  • [36] NOSOCOMIAL METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) PNEUMONIA LINEZOLID OR VANCOMYCIN? - COMPARISON OF PHARMACOLOGY AND CLINICAL EFFICACY
    Pletz, Mathias W.
    Burkhardt, Olaf
    Welte, Tobias
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (12) : 507 - 513
  • [37] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID AND VANCOMYCIN IN PATIENTS WITH COMPLICATED SKIN AND SOFT-TISSUE INFECTIONS CAUSED BY METHICILIN-RESISTANT STAPHYLOCOCCUS IN PORTUGAL
    Ines, M.
    Saramago, P.
    Pinto, A.
    VALUE IN HEALTH, 2013, 16 (07) : A506 - A506
  • [38] Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus
    Mullins, C. Daniel
    Kuznik, Andreas
    Shaya, Fadia T.
    Obeidat, Nour A.
    Levine, Andrew R.
    Liu, Larry Z.
    Wong, Winston
    CLINICAL THERAPEUTICS, 2006, 28 (08) : 1184 - 1198
  • [39] Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial
    Collins, Curtis D.
    Schwemm, Ann K.
    VALUE IN HEALTH, 2015, 18 (05) : 614 - 621
  • [40] Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
    Stevens, DL
    Smith, LG
    Bruss, JB
    McConnell-Martin, MA
    Duvall, SE
    Todd, WM
    Hafkin, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) : 3408 - 3413
12345